COVID Vaccines: US FDA Seeks Panel Vote On New Formulation Targeting JN.1 Variant

 
• By Sue Sutter
  
Global
Recent epidemiology in the US could complicate the global drive for alignment on COVID-19 vaccine formulations. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers